Akili is developing video game-based digital medicine to improve cognitive function. The company uses features of the tech and entertainment industries to develop it's digital treatment and address inattention in children with attention deficit hyperactivity disorder.

Founded2011
Total Funding to Date$275.08MM
Register for Details

For more details on financing and valuation for Akili, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Akili Ticker Symbol

Akili does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Akili Stock Price

The stock price for Akili will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Akili Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/26/2021 Series D $151.68MM raised $XXX.XX $XXX.XX
5/9/2018 Series C $68.2MM raised $XXX.XX $XXX.XX
7/20/2016 Series B $42.36MM raised $XXX.XX $XXX.XX
2/19/2012 Series A-1 and A-2 $12.83MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Akili in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector